Dyadic International Inc., a biotechnology company, is set to participate in the BioProcess International BPI East from September 15-18, 2025. Joe Hazelton, the company's President & Chief Operating Officer, will present at the event. Dyadic specializes in the scalable production of high-value, precision-engineered functional input proteins for various non-therapeutic applications.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dyadic International Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9522610-en) on September 04, 2025, and is solely responsible for the information contained therein.